2nd May 2013 13:45
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | ||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||||||||||
An acquisition or disposal of voting rights | |||||||||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | X | ||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||||||||||
An event changing the breakdown of voting rights | |||||||||||||
Other (please specify): |
| ||||||||||||
3. Full name of person(s) subject to the notification obligation:
| Smith and Williamson Holdings Limited | ||||||||||||
4. Full name of shareholder(s) (if different from 3.):
| Detailed as per section 9 | ||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached:
| 22/04/2013 | ||||||||||||
6. Date on which issuer notified:
| 23/04/2013 | ||||||||||||
7. Threshold(s) that is/are crossed or reached:
| 11% | ||||||||||||
8. Notified details: | |||||||||||||
A: Voting rights attached to shares
| |||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||||
Ordinary GB0034251727 | 23,477,100 | 23,477,100 | 21,477,100 | 10.26% | |||||||||
B: Qualifying Financial Instruments | |||||||||||||
Resulting situation after the triggering transaction
| |||||||||||||
Type of financialinstrument
| Expirationdate | Exercise/ConversionPeriod | Number of votingrights that may beacquired if theinstrument isexercised/ converted.
| % of votingrights | |||||||||
N/A | N/A | N/A | N/A | N/A | |||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
Resulting situation after the triggering transaction
| ||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights
| |
Nominal | Delta
| |||||
Total (A+B+C)
| |
Number of voting rights | Percentage of voting rights |
21,477,100 | 10.26% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | |
Smith and Williamson Nominees Limited, a subsidiary of Smith and Williamson Investment Management Limited, a subsidiary of Smith and Williamson Holdings Limited - 5,056,157 shares
Royal Bank of Scotland as custodian for Smith & Williamson Fund Administration Ltd, a subsidiary of Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 2,000,000 shares
BNP Paribas as custodian for Smith and Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Limited - 675,000 shares
BNP Paribas Securities Services as custodian for Smith & Williamson Investment Management (Ireland) Limited, a subsidiary of Smith & Williamson Holdings Limited - 14,000,000 shares
| |
Proxy Voting:
| |
10. Name of the proxy holder:
| N/A |
11. Number of voting rights proxy holder will cease to hold:
| N/A |
12. Date on which proxy holder will cease to hold voting rights:
| N/A |
13. Additional information:
| |
14. Contact name:
| Not advised |
15. Contact telephone number:
| Not advised |
Related Shares:
PVG.L